Pharmacy and other service costs increased 6%, reflecting higher specialty claims volume as well as inflation on, and higher sales of, branded drugs. Medical costs and other benefit expenses increased 9%, primarily reflecting an increased insured customer base (primarily within our Individual business) and trend in Cigna Healthcare, partially offset by the impact of the Chubb transaction. Interest expense and other increased 20%, primarily reflecting higher interest rates on our indebtedness and increased p ...

| --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Cigna Corporation (NYSE:CI) Q4 2022 Earnings Conference Call February 3, 2023 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President & Head of Investor Relations David Cordani - President & Chief Executive Officer Brian Evanko - Executive Vice President & Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Gary Taylor - Cowen Erin Wright - Morgan Stanley Kevin Fischbeck - BofA Securities Scott Fidel - Stephens Inc. Justin Lake - Wolfe Research Lisa Gill - JPMorgan ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This press release, and oral statements made in connection with this release, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna's current expectations and projections about future tr ...

Cigna Corporation (NYSE:CI) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President & Head of Investor Relations David Cordani - President & Chief Executive Officer Brian Evanko - Executive Vice President & Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Lisa Gill - JPMorgan Josh Raskin - Nephron Research Lindsay Golub ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-38769 Cigna Corporation (Exact name of registrant as specified in its charter) Delaware 82-4991898 (State or other jurisdic ...

Diversified Healthcare Trust (DHC) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President & Head of Investor Relations David Cordani - President & Chief Executive Officer Brian Evanko - Executive Vice President & Chief Financial Officer Conference Call Participants Matthew Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Dave Windley - Jefferies A.J. Rice - Credit Suisse Justin Lake - Wolfe Research ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-38769 Cigna Corporation (Exact name of registrant as specified in its charter) Delaware 82-4991898 (State or other jurisdiction ...

| --- | --- | --- | |-------|-------|---------| | | | | | | | | | | | Cigna。 | | | | | | | | | WELCOME CIGNA INVESTOR DAY 2022 RALPH GIACOBBE, SENIOR VICE PRESIDENT AND HEAD OF INVESTOR RELATIONS, CIGNA Confidential, unpublished property of Cigna. Do not duplicate or distribute. Use and distribution limited solely to authorized personnel. © 2022 Cigna | --- | --- | |--------|-----------------------| | | | | | | | | OPENING REMARKS | | | EVERNORTH | | | CIGNA HEALTHCARE | | AGENDA | FINANCIAL COMMITMENTS | | ...

| --- | --- | |----------------------------------------------|-------| | | | | | | | | | | | | | | | | HEALTHY | | | GROWTH | | | CIGNA INVESTOR PRESENTATION \| MAY 6, 2022 | | | | | Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This presentation, and oral statements made with respect to information contained in this presentation, may contain forward-looking statements within the meaning of the Private Sec ...